Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 3/20 | 0.33 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.33 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.33 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44489 | 0.86 | — | — | |
| SCHEMBL2904699 | 0.86 | — | — | |
| SCHEMBL2905861 | 0.86 | — | — | |
| SCHEMBL6009745 | 0.84 | LMNA (0.46) | SLC22A6CYP1A2KDM4ELMNADUSP3 | |
| Ammonia Solution, Strong SCHEMBL29173217 | 0.84 | LMNA (0.46) | SLC22A6CYP1A2KDM4ELMNADUSP3 | |
| Bicarbonate SCHEMBL3335344 | 0.84 | LMNA (0.46) | SLC22A6CYP1A2KDM4ELMNADUSP3 | |
| SCHEMBL1525696 | 0.84 | — | — | |
| SCHEMBL5030996 | 0.84 | LMNA (0.46) | SLC22A6CYP1A2KDM4ELMNADUSP3 | |
| SCHEMBL11589388 | 0.82 | THRB (0.42) | SLC22A6KDM4ELMNADUSP3ALDH1A1 | |
| SCHEMBL8033641 | 0.82 | LMNA (0.44) | SLC22A6KDM4ELMNADUSP3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023230217-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-30 | — | — | WO | claimed |
| EP-3700749-B1 | LAMINATE STRUCTURE FOR BIOCOMPATIBLE BARRIER PACKAGING | RENOLIT SE (DE) | 2023-01-11 | — | — | EP | claimed |
| US-11254108-B2 | Laminate structure for biocompatible barrier packaging | RENOLIT SE (DE) | 2022-02-22 | — | — | US | claimed |
| CN-113597436-A | Electrochemical production of polymers | 何慧煌 | 2021-11-02 | — | — | CN | claimed |
| US-20200262186-A1 | LAMINATE STRUCTURE FOR BIOCOMPATIBLE BARRIER PACKAGING | RENOLIT SE (DE) | 2020-08-20 | — | — | US | claimed |
| CN-111448064-A | Layered structure for biocompatible barrier packaging | 雷诺丽特欧洲公司 | 2020-07-24 | — | — | CN | claimed |
| EP-3476594-A1 | LAMINATE STRUCTURE FOR BIOCOMPATIBLE BARRIER PACKAGING | Renolit SE (DE) | 2019-05-01 | — | — | EP | claimed |
| EP-2471559-B1 | Antiviral method | GOJO IND INC (US) | 2014-11-26 | — | — | EP | claimed |
| WO-2014042391-A1 | METHOD OF PREPARING POLYCARBONATE AND POLYCARBONATE PREPARED BY THE SAME | SK INNOVATION CO.,LTD. (KR) | 2014-03-20 | — | — | WO | claimed |
| US-20120172574-A1 | Ring Opening Polymerisation of Cyclic Carbonates With Organic Catalyst Systems | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2012-07-05 | — | — | US | claimed |
| EP-2470585-A1 | RING OPENING POLYMERISATION OF CYCLIC CARBONATES WITH ORGANIC CATALYST SYSTEMS | Total Petrochemicals Research Feluy (BE) | 2012-07-04 | — | — | EP | claimed |
| WO-2011023450-A1 | RING OPENING POLYMERISATION OF CYCLIC CARBONATES WITH ORGANIC CATALYST SYSTEMS | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2011-03-03 | — | — | WO | claimed |
| EP-2289971-A1 | Ring opening polymerisation of cyclic carbonates with organic catalyst systems | Total Petrochemicals Research Feluy (BE) | 2011-03-02 | — | — | EP | claimed |
| WO-2023230217-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230381142-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-30 | — | — | US | disclosed |
| US-10400064-B2 | Glycerol-based polycarbonates | TRUSTEES OF BOSTON UNIVERSITY (US) | 2019-09-03 | — | — | US | disclosed |
| US-20120172574-A1 | Ring Opening Polymerisation of Cyclic Carbonates With Organic Catalyst Systems | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2012-07-05 | — | — | US | disclosed |
| EP-2470585-A1 | RING OPENING POLYMERISATION OF CYCLIC CARBONATES WITH ORGANIC CATALYST SYSTEMS | Total Petrochemicals Research Feluy (BE) | 2012-07-04 | — | — | EP | disclosed |
| WO-2011023450-A1 | RING OPENING POLYMERISATION OF CYCLIC CARBONATES WITH ORGANIC CATALYST SYSTEMS | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2011-03-03 | — | — | WO | disclosed |
| EP-2289971-A1 | Ring opening polymerisation of cyclic carbonates with organic catalyst systems | Total Petrochemicals Research Feluy (BE) | 2011-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10400064-B2 | Glycerol-based polycarbonates | GK, AGPAT5, PC | SLC22A6 403/4885CYP1A2 1666/4885KDM4E 1671/4885 |
| US-20230381142-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | MPO, SSB, SGMS2 | SLC22A6 593/4885CYP1A2 3141/4885KDM4E 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.